Tenecteplase versus standard of care for minor ischaemic stroke with proven occlusion (TEMPO-2): a randomised, open label, phase 3 superiority trial

Coutts SB, Ankolekar S, Appireddy R et al. Lancet. 2024 Jun 15;403(10444):2597-2605. doi: 10.1016/S0140-6736(24)00921-8. Epub 2024 May 17. PMID: 38768626

https://pubmed.ncbi.nlm.nih.gov/38768626/